HHS committee aims to limit FDA oversight of HIT products

08/13/2013 | BeckersHospitalReview.com

Health IT products, with some exceptions, should not be subject to FDA premarket requirements, according to an HHS workgroup asked to create a strategy for these products that would promote innovation while also ensuring patient safety. The workgroup did note that medical device accessories and some high-risk solutions should fall under FDA review. It also recommended post-market safety testing and a public reporting process for HIT products.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Finance Manager - ENT
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA